List of Tables
    Table 1. Molecular Diagnostics Cancer Market Opportunities & Trends in Global Market
    Table 2. Molecular Diagnostics Cancer Market Drivers in Global Market
    Table 3. Molecular Diagnostics Cancer Market Restraints in Global Market
    Table 4. Key Players of Molecular Diagnostics Cancer in Global Market
    Table 5. Top Molecular Diagnostics Cancer Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Molecular Diagnostics Cancer Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Molecular Diagnostics Cancer Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Molecular Diagnostics Cancer Product Type
    Table 9. List of Global Tier 1 Molecular Diagnostics Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Molecular Diagnostics Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Molecular Diagnostics Cancer Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Molecular Diagnostics Cancer Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Molecular Diagnostics Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Molecular Diagnostics Cancer Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Molecular Diagnostics Cancer Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Molecular Diagnostics Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Molecular Diagnostics Cancer Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Molecular Diagnostics Cancer Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Molecular Diagnostics Cancer Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Molecular Diagnostics Cancer Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Molecular Diagnostics Cancer Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Molecular Diagnostics Cancer Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Molecular Diagnostics Cancer Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Corporate Summary
    Table 31. Roche Molecular Diagnostics Cancer Product Offerings
    Table 32. Roche Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 33. Danaher Corporate Summary
    Table 34. Danaher Molecular Diagnostics Cancer Product Offerings
    Table 35. Danaher Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 36. Siemens Corporate Summary
    Table 37. Siemens Molecular Diagnostics Cancer Product Offerings
    Table 38. Siemens Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 39. Abbott Laboratories Corporate Summary
    Table 40. Abbott Laboratories Molecular Diagnostics Cancer Product Offerings
    Table 41. Abbott Laboratories Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 42. ICON Plc Corporate Summary
    Table 43. ICON Plc Molecular Diagnostics Cancer Product Offerings
    Table 44. ICON Plc Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 45. AstraZeneca Corporate Summary
    Table 46. AstraZeneca Molecular Diagnostics Cancer Product Offerings
    Table 47. AstraZeneca Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 48. MDxHealth Corporate Summary
    Table 49. MDxHealth Molecular Diagnostics Cancer Product Offerings
    Table 50. MDxHealth Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 51. Invitae Corporate Summary
    Table 52. Invitae Molecular Diagnostics Cancer Product Offerings
    Table 53. Invitae Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 54. PlexBio Corporate Summary
    Table 55. PlexBio Molecular Diagnostics Cancer Product Offerings
    Table 56. PlexBio Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 57. Thermo Fisher Scientific Corporate Summary
    Table 58. Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offerings
    Table 59. Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 60. Guardant Health Corporate Summary
    Table 61. Guardant Health Molecular Diagnostics Cancer Product Offerings
    Table 62. Guardant Health Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 63. Biocartis Corporate Summary
    Table 64. Biocartis Molecular Diagnostics Cancer Product Offerings
    Table 65. Biocartis Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 66. Bio-Techne Corporate Summary
    Table 67. Bio-Techne Molecular Diagnostics Cancer Product Offerings
    Table 68. Bio-Techne Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 69. Merck Corporate Summary
    Table 70. Merck Molecular Diagnostics Cancer Product Offerings
    Table 71. Merck Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 72. Foundation Medicine Corporate Summary
    Table 73. Foundation Medicine Molecular Diagnostics Cancer Product Offerings
    Table 74. Foundation Medicine Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 75. 10X Genomics Corporate Summary
    Table 76. 10X Genomics Molecular Diagnostics Cancer Product Offerings
    Table 77. 10X Genomics Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 78. Biodesix Corporate Summary
    Table 79. Biodesix Molecular Diagnostics Cancer Product Offerings
    Table 80. Biodesix Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 81. CytoTrack Corporate Summary
    Table 82. CytoTrack Molecular Diagnostics Cancer Product Offerings
    Table 83. CytoTrack Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 84. GenomOncology Corporate Summary
    Table 85. GenomOncology Molecular Diagnostics Cancer Product Offerings
    Table 86. GenomOncology Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
    Table 87. Luminex Corporate Summary
    Table 88. Luminex Molecular Diagnostics Cancer Product Offerings
    Table 89. Luminex Molecular Diagnostics Cancer Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Molecular Diagnostics Cancer Segment by Type in 2021
    Figure 2. Molecular Diagnostics Cancer Segment by Application in 2021
    Figure 3. Global Molecular Diagnostics Cancer Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Molecular Diagnostics Cancer Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Molecular Diagnostics Cancer Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2021
    Figure 8. By Type - Global Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 12. US Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 16. Germany Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 17. France Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 24. China Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 28. India Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 30. Brazil Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Molecular Diagnostics Cancer Revenue Market Share, 2017-2028
    Figure 33. Turkey Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Molecular Diagnostics Cancer Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Danaher Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Siemens Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Abbott Laboratories Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. ICON Plc Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AstraZeneca Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. MDxHealth Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Invitae Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. PlexBio Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Guardant Health Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Biocartis Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Bio-Techne Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Merck Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Foundation Medicine Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. 10X Genomics Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Biodesix Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. CytoTrack Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. GenomOncology Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Luminex Molecular Diagnostics Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)